Document text
Principal Investigator: Brandon Blake Holmes
Organization: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Fiscal Year: 2024
Award: $210,306
Funding agency: National Institute of Neurological Disorders and Stroke
Alzheimer's disease (AD) is an intractable neurodegenerative disorder that devastates approximately 6.2 million Americans nationwide. Emerging evidence now establishes a central role for microglia in AD pathogenesis and reveals that transcriptional and epigenetic level changes in these cells tightly correlate with disease progression. Thus, targeting microglia with selective pharmacologic agents to control their cellular activity represents a powerful therapeutic avenue. However, precise microglia targeting requires broad knowledge of how the cell-surface proteome, or surfaceome, remodels in the disease environment, and this biology has not been systematically explored. I performed mass spectrometry-based surfaceome profiling of microglia after exposure to Aβ fibrils. My data revealed a robust upregulation of heparan sulfate proteoglycans and proteins that promote phagocytosis. In Aim 1 of this proposal, I will directly test if Aβ-induced heparan sulfate proteoglycans result in increased tau phagocytosis and seeding in human iPSC microglia. This hypothesis represents a unique framework that mechanistically links Aβ and tau pathology through microglia phagocytosis. In Aim 2, I will determine the tissue expression patterns of heparan sulfate proteoglycan in human AD brain. Finally, in Aim 3, I will engineer novel cell-surface degrading antibodies, called KineTACs, to specifically degrade disease-associated microglia targets from the cell-surface. The work outlined within this proposal is innovative and will greatly increase our understanding of microglia phagocytosis in AD and provide new recombinant tools to modulate this process. With the strong support of my scientific mentors and advisors at the University of California San Francisco, this K08 training proposal will enable me to cultivate mastery in iPSC cell culture models, human immunohistochemistry, and recombinant antibody engineering. This trajectory constitutes the first steps toward a broader career goal of becoming an independent physician-scientist studying the cellular and molecular mechanisms of neurodegeneration.
Terms: <AD dementia><AD pathology><Alzheimer Type Dementia><Alzheimer beta-Protein><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Amyloid beta-Protein><Alzheimer's Disease><Alzheimer's amyloid><Alzheimer's brain><Alzheimer's disease brain><Alzheimer's disease pathology><Alzheimer's pathology><Alzheimers Dementia><American><Amyloid><Amyloid (Aβ) plaques><Amyloid Alzheimer's Dementia Amyloid Protein><Amyloid Beta-Peptide><Amyloid Plaques><Amyloid Protein A4><Amyloid Proteins><Amyloid Substance><Amyloid beta-Protein><Amyloid β><Amyloid β-Peptide><Amyloid β-Protein><Antibodies><Assay><Autopsy><Aβ><Bi-specific antibodies><Bifunctional Antibodies><Binding><Bioassay><Biological><Biological Assay><Biology><Bispecific Antibodies><Body Tissues><Brain Diseases><Brain Disorders><CRISPR activation><CRISPR activator><CRISPR based activation><CRISPR gene activation><CRISPR transcription activation><CRISPR transcriptional activation><CRISPR-Cas-9-mediated gene activation><CRISPR-based gene activation><CRISPR-dCAS9 Activator><CRISPR-mediated transcriptional activation><CRISPR/CAS9 activation><CRISPR/CAS9 gene activation><CRISPR/dCas9 activation><CRISPR/dCas9-based transcriptional activation><CRISPRa><California><Cancers><Cell Body><Cell Communication and Signaling><Cell Culture Techniques><Cell Signaling><Cell Surface Proteins><Cell Surface Receptors><Cell fusion><Cell surface><Cells><Complex><Core Protein><Data><Data Set><Degenerative Neurologic Disorders><Diathesis><Disease><Disease Progression><Disease associated microglia><Disease susceptibility><Disorder><Encephalon Diseases><Engineering><Environment><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Exhibits><Exposure to><Funding><Future><GWA study><GWAS><Gene Transcription><Gene variant><Genes><Genetic Transcription><Glypican><Goals><HSPG><Heparan Sulfate Proteoglycan><Hortega cell><Human><Immune><Immunes><Immunohistochemistry><Immunohistochemistry Cell/Tissue><Immunohistochemistry Staining Method><Inflammatory><Intracellular Communication and Signaling><Intracranial CNS Disorders><Intracranial Central Nervous System Disorders><Invaded><Investigation><Investigators><Knowledge><Link><Lysosomes><MT-bound tau><Malignant Neoplasms><Malignant Tumor><Mass Photometry/Spectrum Analysis><Mass Spectrometry><Mass Spectroscopy><Mass Spectrum><Mass Spectrum Analyses><Mass Spectrum Analysis><Mediator><Mentors><Methods><Microglia><Modeling><Modern Man><Molecular><Molecular Interaction><Nerve Degeneration><Nervous System Degenerative Diseases><Network Analysis><Neural Degenerative Diseases><Neural degenerative Disorders><Neuritic Plaques><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurofibrillary Tangles><Neurologic Degenerative Conditions><Neuron Degeneration><Neurosciences><Outcome><Pathogenesis><Pathologic><Pathology><Pathway Analysis><Pattern><Phagocytosis><Physicians><Primary Senile Degenerative Dementia><Process><Proteins><Proteoheparan Sulfate><Proteome><Proteomics><RNA Expression><Reaction><Receptor Protein><Recombinant Antibody><Recombinants><Reporter><Research><Research Personnel><Researchers><Role><Route><San Francisco><Scientist><Senile Plaques><Signal Transduction><Signal Transduction Systems><Signaling><Surface><TREM2><TREM2 gene><Technology><Testing><Therapeutic><Therapeutic Agents><Tissues><Toxin><Training><Transcription><Triggering Receptor Expressed in Myeloid Cells 2><Triggering Receptor Expressed on Myeloid Cells 2><Universities><Up-Regulation><Upregulation><Work><a beta peptide><abeta><abnormally aggregated tau protein><activating CRISPR technology><allele variant><allelic variant><amyloid beta><amyloid beta plaque><amyloid-b plaque><amyloid-b protein><antibody engineering><aβ plaques><beta amyloid associated pathology><beta amyloid fibril><beta amyloid pathology><biologic><biological signal transduction><brain cell><brain tissue><bsAb><career><cell culture><cell cultures><chondroitin sulfate proteoglycan core glycoprotein><cored plaque><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><dermatan sulfate glycoprotein core protein><design><designing><diffuse plaque><drug discovery><epigenetically><epigenomics><exosome><extracellular><filamentous tau inclusion><genetic variant><genome wide association><genome wide association scan><genome wide association studies><genome wide association study><genomewide association scan><genomewide association studies><genomewide association study><genomic variant><gitter cell><glycoproteomics><hiPSC><human iPS><human iPSC><human induced pluripotent cell><human induced pluripotent stem cells><human inducible stem cells><iPS><iPSC><iPSCs><induced human pluripotent stem cells><induced pluripotent cell><induced pluripotent stem cell><inducible pluripotent stem cell><injury response><innovate><innovation><innovative><interest><liability to disease><live cell image><live cell imaging><live cellular image><live cellular imaging><malignancy><mesoglia><microglial cell><microgliocyte><microtubule associated protein tau aggregation><microtubule associated protein tau deposit><microtubule bound tau><microtubule-bound tau><necropsy><neoplasm/cancer><neural degeneration><neural inflammation><neurodegeneration><neurodegenerative><neurodegenerative illness><neurofibrillary degeneration><neurofibrillary lesion><neurofibrillary pathology><neuroinflammation><neuroinflammatory><neurological degeneration><neuronal degeneration><neuroprotection><neuroprotective><neurotoxic><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><paired helical filament of tau><pathogen><perivascular glial cell><pharmacologic><postmortem><primary degenerative dementia><proteoglycan core protein><receptor><response><response to injury><self-aggregate tau><senile dementia of the Alzheimer type><social role><soluble amyloid precursor protein><tangle><tau><tau PHF><tau Proteins><tau accumulation><tau aggregate><tau aggregation><tau factor><tau fibrillization><tau filament><tau neurofibrillary tangle><tau oligomer><tau paired helical filament><tau polymerization><tau-tau interaction><tool><uptake><whole genome association analysis><whole genome association studies><whole genome association study><β-amyloid pathology><τ Proteins><τ aggregation>